158 related articles for article (PubMed ID: 23418605)
1. Insulin-like growth factor receptor I (IGF-IR) and vascular endothelial growth factor receptor 2 (VEGFR-2) are expressed on the circulating epithelial tumor cells of breast cancer patients.
Pizon M; Zimon DS; Pachmann U; Pachmann K
PLoS One; 2013; 8(2):e56836. PubMed ID: 23418605
[TBL] [Abstract][Full Text] [Related]
2. B7-H3 on circulating epithelial tumor cells correlates with the proliferation marker, Ki-67, and may be associated with the aggressiveness of tumors in breast cancer patients.
Pizon M; Schott DS; Pachmann U; Pachmann K
Int J Oncol; 2018 Nov; 53(5):2289-2299. PubMed ID: 30226585
[TBL] [Abstract][Full Text] [Related]
3. Influence of endocrine therapy on the ratio of androgen receptor (AR) to estrogen receptor (ER) positive circulating epithelial tumor cells (CETCs) in breast cancer.
Pizon M; Lux D; Pachmann U; Pachmann K; Schott D
J Transl Med; 2018 Dec; 16(1):356. PubMed ID: 30547831
[TBL] [Abstract][Full Text] [Related]
4. The number of tumorspheres cultured from peripheral blood is a predictor for presence of metastasis in patients with breast cancer.
Pizon M; Schott D; Pachmann U; Pachmann K
Oncotarget; 2016 Jul; 7(30):48143-48154. PubMed ID: 27340862
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of insulin-like growth factor-I receptor and insulin receptor substrate-1 expression in advanced human breast cancer.
Schnarr B; Strunz K; Ohsam J; Benner A; Wacker J; Mayer D
Int J Cancer; 2000 Nov; 89(6):506-13. PubMed ID: 11102895
[TBL] [Abstract][Full Text] [Related]
6. Sensitive detection of PD-L1 expression on circulating epithelial tumor cells (CETCs) could be a potential biomarker to select patients for treatment with PD-1/PD-L1 inhibitors in early and metastatic solid tumors.
Schott DS; Pizon M; Pachmann U; Pachmann K
Oncotarget; 2017 Sep; 8(42):72755-72772. PubMed ID: 29069824
[TBL] [Abstract][Full Text] [Related]
7. Influence of adjuvant radiotherapy on circulating epithelial tumor cells and circulating cancer stem cells in primary non-metastatic breast cancer.
Schott DS; Pizon M; Pachmann U; Pachmann K; Schobert R; Wittig A; Mäurer M
Transl Oncol; 2021 Mar; 14(3):101009. PubMed ID: 33453469
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-β, insulin-like growth factor I/insulin-like growth factor I receptor and vascular endothelial growth factor-A: prognostic and predictive markers in triple-negative and non-triple-negative breast cancer.
Bahhnassy A; Mohanad M; Shaarawy S; Ismail MF; El-Bastawisy A; Ashmawy AM; Zekri AR
Mol Med Rep; 2015 Jul; 12(1):851-64. PubMed ID: 25824321
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of epidermal growth factor receptor and vascular endothelial growth factor receptor in colorectal adenocarcinoma.
Kim JY; Bae BN; Kwon JE; Kim HJ; Park K
APMIS; 2011 Jul; 119(7):449-59. PubMed ID: 21635552
[TBL] [Abstract][Full Text] [Related]
10. Effects of VEGFR-1, VEGFR-2, and IGF-IR hammerhead ribozymes on glucose-mediated tight junction expression in cultured human retinal endothelial cells.
Spoerri PE; Afzal A; Li Calzi S; Shaw LC; Cai J; Pan H; Boulton M; Grant MB
Mol Vis; 2006 Jan; 12():32-42. PubMed ID: 16446700
[TBL] [Abstract][Full Text] [Related]
11. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-1 receptor (IGF-1R) expression on circulating tumor cells (CTCs) and metastatic breast cancer outcome: results from the TransMYME trial.
Gennari A; Foca F; Zamarchi R; Rocca A; Amadori D; De Censi A; Bologna A; Cavanna L; Gianni L; Scaltriti L; Rossi E; Facchinetti A; Martini V; Bruzzi P; Nanni O
Breast Cancer Res Treat; 2020 May; 181(1):61-68. PubMed ID: 32200486
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-I receptor (IGF-IR) translocates to nucleus and autoregulates IGF-IR gene expression in breast cancer cells.
Sarfstein R; Pasmanik-Chor M; Yeheskel A; Edry L; Shomron N; Warman N; Wertheimer E; Maor S; Shochat L; Werner H
J Biol Chem; 2012 Jan; 287(4):2766-76. PubMed ID: 22128190
[TBL] [Abstract][Full Text] [Related]
14. Inducible expression of dominant negative insulin-like growth factor I receptor in MCF-7 breast cancer cells.
Modha G; Blanchard A; Sidorchuk J; Venditti M; Shiu R; Myal Y
Endocrine; 2003 Dec; 22(3):293-303. PubMed ID: 14709803
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival.
Law JH; Habibi G; Hu K; Masoudi H; Wang MY; Stratford AL; Park E; Gee JM; Finlay P; Jones HE; Nicholson RI; Carboni J; Gottardis M; Pollak M; Dunn SE
Cancer Res; 2008 Dec; 68(24):10238-46. PubMed ID: 19074892
[TBL] [Abstract][Full Text] [Related]
16. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients.
Kallergi G; Markomanolaki H; Giannoukaraki V; Papadaki MA; Strati A; Lianidou ES; Georgoulias V; Mavroudis D; Agelaki S
Breast Cancer Res; 2009; 11(6):R84. PubMed ID: 19919679
[TBL] [Abstract][Full Text] [Related]
18. The expression difference of insulin-like growth factor 1 receptor in breast cancers with or without diabetes.
Xin C; Jing D; Jie T; Wu-Xia L; Meng Q; Ji-Yan L
J Cancer Res Ther; 2015; 11(2):295-9. PubMed ID: 26148588
[TBL] [Abstract][Full Text] [Related]
19. Monitoring of circulating epithelial tumor cells using the Maintrac
Gold M; Pachmann K; Kiani A; Schobert R
Mol Clin Oncol; 2021 Oct; 15(4):201. PubMed ID: 34462657
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic significance of VEGF receptors, VEGFR-1 (Flt-1) and VEGFR-2 (KDR/Flk-1) in breast carcinoma].
Dales JP; Garcia S; Bonnier P; Duffaud F; Carpentier S; Djemli A; Ramuz O; Andrac L; Lavaut M; Allasia C; Charpin C
Ann Pathol; 2003 Sep; 23(4):297-305. PubMed ID: 14597894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
